ArticleAlzheimer's & dementia (New York, N. Y.)2018

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.

Brian A Willis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.